Online inquiry

IVTScrip™ mRNA-Human ARHGAP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK28580MR)

This product GTTS-WK28580MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARHGAP1 protein. This product can be used in Microglial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_004308.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 392
UniProt ID Q07960
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGAP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK28580MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK25914MR IVTScrip™ mRNA-Human ARHGEF26, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARHGEF26
GTTS-WK19168MR IVTScrip™ mRNA-Human AOAH, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA AOAH
GTTS-WK11173MR IVTScrip™ mRNA-Human ABI1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ABI1
GTTS-WK20236MR IVTScrip™ mRNA-Human alpha-Sarcoglycan, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA alpha-Sarcoglycan
GTTS-WK21740MR IVTScrip™ mRNA-Human ARL3, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ARL3
GTTS-WK9471MR IVTScrip™ mRNA-Human ACTR2, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ACTR2
GTTS-WK10780MR IVTScrip™ mRNA-Human AFAP1L2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AFAP1L2
GTTS-WK13430MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA Additional GABA Compounds
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW